ENCell, a South Korean cell and gene developer/CDMO, has been recognized for its cutting-edge technology and expertise. They aim to develop therapeutics that contribute to improving patients' quality of life and overcoming diseases. In addition, through their CDMO services, ENCell supports clients in efficiently executing product development and manufacturing by leveraging their specialized technology and advanced facilities.